(Q34308997)

English

Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Gianluca Gaidano

10

object named as

Gianluca Gaidano

2 references

Europe PubMed Central

PubMed publication ID

1 August 2017

ORCID Public Data File 2021

object named as

Michele Spina

12

1 reference

ORCID Public Data File 2021

Massimo Federico

object named as

Massimo Federico

20

1 reference

ORCID Public Data File 2021

author name string

Angelo M Carella

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Carmino A de Souza

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Stefano Luminari

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Luigi Marcheselli

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Annalisa Chiappella

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Alice di Rocco

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Marina Cesaretti

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Andrea Rossi

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Luigi Rigacci

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Francesco Merli

11

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Caterina Stelitano

13

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Stefan Hohaus

14

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Anna Barbui

15

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Benedetta Puccini

16

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Eliana C Miranda

17

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Annalisa Guida

18

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Massimo Federico

19

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

28 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

53-57

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma - a population-based study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

How I treat elderly patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

Bayesian information criterion for censored survival models.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

The advantage of women in cancer survival: an analysis of EUROCARE-4 data

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

Clinical pharmacokinetics of bevacizumab in patients with solid tumors.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

Interindividual variability of response to rituximab: from biological origins to individualized therapies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.691482

21 January 2018

Identifiers

10.3109/10428194.2012.691482

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34308997&oldid=2095826164"